Skip to main content
. Author manuscript; available in PMC: 2020 Sep 21.
Published in final edited form as: Eur J Cancer. 2018 Feb 3;92:20–32. doi: 10.1016/j.ejca.2017.12.023

Table 1.

Association of patient characteristics with lower PCS score.

Characteristic N (%)a PCS score
Unadjusted
P value Adjustedb
P value
≥45.7 32.7–45.7 <32.7 OR (95% CI) OR (95% CI)
Sex
 Male 1,489 (60.1) 498 517 474 1.00 (Ref) 1.00 (Ref)
 Female 989 (39.9) 294 325 370 1.23 (1.06–1.43) 0.005 1.10 (0.93–1.30) 0.29
Age at diagnosis, yrs
 18–44 162 (6.5) 45 56 61 1.00 (Ref) 1.00 (Ref)
 45–54 534 (21.5) 165 197 172 0.82 (0.60–1.14) 0.24 0.83 (0.59–1.17) 0.29
 55–64 888 (35.8) 306 303 279 0.75 (0.55–1.02) 0.06 0.76 (0.54–1.05) 0.10
 65–74 651 (26.3) 207 214 230 0.87 (0.63–1.19) 0.38 0.91 (0.65–1.29) 0.60
 ≥75 243 (9.8) 69 72 102 1.10 (0.76–1.59) 0.61 1.06 (0.71–1.60) 0.77
P for trend 0.29 0.35
Marital status
 Married 1952 (78.8) 640 684 628 1.00 (Ref) 1.00 (Ref)
 Never married 203 (8.2) 61 66 76 1.20 (0.92–1.57) 0.18 1.10 (0.83–1.46) 0.50
 Divorced 138 (5.6) 44 38 56 1.25 (0.90–1.73) 0.18 1.11 (0.79–1.56) 0.55
 Widowed 167 (6.7) 42 51 74 1.58 (1.18–2.13) 0.002 1.10 (0.79–1.54) 0.58
 Others 18 (0.7) 5 3 10 2.09 (0.83–5.29) 0.12 2.91 (1.13–7.51) 0.03
Race
 Non-Hispanic whites 1966 (79.3) 678 655 633 1.00 (Ref) 1.00 (Ref)
 African-Americans 166 (6.7) 34 54 78 1.94 (1.44–2.61) <0.001 1.33 (0.97–1.83) 0.07
 Hispanics 186 (7.5) 34 72 80 1.81 (1.38–2.39) <0.001 1.69 (1.26–2.26) <0.001
 Others 160 (6.5) 46 61 53 1.16 (0.87–1.55) 0.32 1.01 (0.74–1.39) 0.93
Education
 < High school 171 (6.9) 29 55 87 1.00 (Ref) 1.00 (Ref)
 High school/vocational 681 (27.5) 190 199 292 0.65 (0.47–0.89) 0.008 0.80 (0.57–1.12) 0.19
 ≥ College degree 1508 (60.9) 540 545 423 0.38 (0.28–0.52) <0.001 0.59 (0.42–0.83) <0.001
 Unknown 118 (4.8) 33 43 42 0.54 (0.35–0.84) 0.006 0.69 (0.43–1.10) 0.12
P for trend <0.001 <0.001
Occupation
 White collar 914 (36.9) 307 339 268 1.00 (Ref) 1(reference)
 Blue collar 311 (12.6) 81 114 116 1.41 (1.12–1.78) 0.004 1.12 (0.86–1.45) 0.40
 Others 164 (6.6) 55 56 53 1.07 (0.79–1.45) 0.67 0.83 (0.60–1.15) 0.26
 Unknown 1089 (43.9) 349 333 407 1.24 (1.06–1.46) 0.008 1.10 (0.92–1.31) 0.30
Smoking status
 Never 1122 (45.6) 373 382 367 1.00 (Ref) 1.00 (Ref)
 Former 1056 (42.9) 345 367 344 1.01 (0.87–1.18) 0.90 1.07 (0.91–1.26) 0.43
 Current 282 (11.5) 72 83 127 1.60 (1.25–2.04) <0.001 1.59 (1.23–2.06) <0.001
P for trend 0.004 0.003
Alcohol use
 Never 1030 (41.8) 275 329 426 1.00 (Ref) 1.00 (Ref)
 Former 671 (27.3) 171 248 252 0.93 (0.78–1.11) 0.44 0.93 (0.77–1.13) 0.47
 Current 761 (30.9) 344 255 162 0.41 (0.34–0.49) <0.001 0.46 (0.38–0.55) <0.001
P for trend <0.001 <0.001
Tumour size
 0–20 mm 105 (4.2) 44 35 26 1.00 (Ref) 1.00 (Ref)
 21–30 mm 233 (9.4) 94 81 58 1.04 (0.68–1.60) 0.85 1.20 (0.77–1.88) 0.42
 >30 mm 526 (21.2) 173 174 179 1.52 (1.03–2.24) 0.04 1.40 (0.92–2.13) 0.11
 Unknown 1614 (65.1) 481 552 581 1.70 (1.18–2.45) 0.004 1.49 (0.99–2.25) 0.06
P for trend <0.001 0.04
AJCC cancer stage
 I 97 (3.9) 45 33 19 1.00 (Ref) 1.00 (Ref)
 II 221 (8.9) 103 66 52 1.07 (0.69–1.67) 0.77 1.08 (0.68–1.72) 0.75
 III 162 (6.5) 58 54 50 1.64 (1.03–2.62) 0.04 1.80 (1.10–2.94) 0.02
 IV 533 (21.5) 140 184 209 2.47 (1.65–3.69) <0.001 2.32 (1.50–3.59) <0.001
 Unknown 1465 (59.1) 446 505 514 2.05 (1.40–3.00) <0.001 1.72 (1.12–2.65) 0.01
P for trend <0.001 <0.001
Metastatic site(s)
 1 239 (44.8) 64 76 99 1.00 (Ref)
 ≥2 294 (55.2) 76 108 110 0.92 (0.67–1.26) 0.61 0.89 (0.64–1.25) 0.52
Comorbidity
 No 721 (29.1) 268 255 198 1.00 (Ref) 1.00 (Ref)
 Yes 1757 (70.9) 524 587 646 1.46 (1.24–1.71) <0.001 1.39 (1.17–1.65) <0.001
Heart disease
 No 2003 (80.8) 666 679 658 1.00 (Ref) 1.00 (Ref)
 Yes 475 (19.2) 126 163 186 1.30 (1.06–1.60) 0.002 1.30 (1.06–1.60) 0.01
Lung disease
 No 2281 (92.1) 751 783 747 1.00 (Ref) 1.00 (Ref)
 Yes 197 (7.9) 41 59 97 1.95 (1.48–2.57) <0.001 1.86 (1.39–2.48) <0.001
Diabetes
 No 1825 (73.6) 635 625 565 1.00 (Ref) 1.00 (Ref)
 Yes 653 (26.4) 157 217 279 1.67 (1.42–1.97) <0.001 1.43 (1.19–1.72) <0.001
Hypertension
 No 1343 (54.2) 470 449 424 1.00 (Ref) 1.00 (Ref)
 Yes 1135 (45.8) 322 393 420 1.31 (1.14–1.52) <0.001 1.11 (0.92–1.34) 0.27
Liver disease
 No 2343 (94.6) 759 796 788 1.00 (Ref) 1.00 (Ref)
 Yes 135 (5.4) 33 46 56 1.43 (1.04–1.97) 0.03 1.06 (0.76–1.49) 0.72
Renal disease
 No 2210 (89.0) 729 756 725 1.00 (Ref) 1.00 (Ref)
 Yes 268 (10.8) 63 86 119 1.62 (1.28–2.06) <0.001 1.48 (1.14–1.91) <0.001
Infectious disease
 No 2439 (98.4) 786 829 824 1.00 (Ref) 1.00 (Ref)
 Yes 39 (1.6) 6 13 20 2.19 (1.21–3.97) 0.01 1.85 (0.99–3.43) 0.05
Stroke
 No 2397 (96.7) 786 812 799 1.00 (Ref) 1.00 (Ref)
 Yes 81 (3.3) 6 30 45 2.89 (1.90–4.39) <0.001 2.57 (1.65–3.99) <0.001
Digestive tract bleeding
 No 2420 (97.7) 780 825 815 1.00 (Ref) 1.00 (Ref)
 Yes 58 (2.3) 12 17 29 1.93 (1.17–3.16) 0.01 1.55 (0.93–2.60) 0.09
Seizure
 No 2449 (98.8) 786 835 828 1.00 (Ref) 1.00 (Ref)
 Yes 29 (1.2) 6 7 16 2.24 (1.09–4.57) 0.03 1.83 (0.87–3.83) 0.11
Time since diagnosisc
 < 1 month 1174 (47.4) 429 375 370 1.00 (Ref) 1.00 (Ref)
 1–3 months 890 (35.9) 226 326 338 1.49 (1.27–1.74) <0.001 1.27 (1.07–1.52) 0.007
 3–6 months 218 (8.8) 64 72 82 1.36 (1.04–1.77) 0.03 1.10 (0.79–1.52) 0.58
 ≥ 6 months 196 (7.9) 73 69 54 0.90 (0.68–1.19) 0.47 0.83 (0.59–1.16) 0.28
P for trend 0.17 0.99
Years of diagnosis
 1999–2001 218 (8.8) 59 79 80 1.00 (Ref) 1.00 (Ref)
 2002–2004 355 (14.3) 109 110 136 0.96 (0.71–1.31) 0.81 0.97 (0.70–1.34) 0.86
 2005–2007 632 (25.5) 204 215 213 0.83 (0.63–1.10) 0.20 0.87 (0.64–1.17) 0.35
 2008–2010 820 (33.1) 269 275 276 0.82 (0.63–1.08) 0.16 0.89 (0.66–1.18) 0.41
 2011–2012 453 (18.3) 151 163 139 0.76 (0.57–1.02) 0.07 0.87 (0.64–1.20) 0.40
P for trend 0.03 0.34

Abbreviations: AJCC, American Joint Committee on Cancer; CI, confidence interval; OR, odds ratio; PCS, Physical Component Summary.

a

Missing values not included: smoking status (N = 18); alcohol status (N = 16), percentages may not add up to 100% due to rounding.

b

Adjusted for sex, age, marital status, race, education level, occupation, smoking, alcohol use, tumour size, cancer stage, comorbidity, treatment before survey, time since diagnosis and years of diagnosis if appropriate.

c

The interval between initial diagnosis and quality-of-life survey.